Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.190
-0.050 (-2.23%)
At close: Apr 28, 2026, 4:00 PM EDT
2.174
-0.016 (-0.75%)
After-hours: Apr 28, 2026, 7:44 PM EDT
Daré Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -13.4 | -4.05 | -30.16 | -30.95 | -38.7 | |
| Depreciation & Amortization | 1.63 | 0.04 | 0.04 | 0.02 | 0.03 | |
| Loss (Gain) From Sale of Assets | - | 0.6 | - | - | - | |
| Stock-Based Compensation | 1.5 | 2.2 | 2.53 | 2.16 | 1.6 | |
| Other Operating Activities | 0.59 | 0.79 | -0.84 | -0.02 | -0.42 | |
| Change in Accounts Receivable | -0.01 | - | 0.75 | -0.56 | -0.69 | |
| Change in Accounts Payable | -0.26 | -1.93 | 1.36 | -0.08 | 1.08 | |
| Change in Unearned Revenue | 2.09 | 2.82 | -4.57 | 7.76 | 8.98 | |
| Change in Other Net Operating Assets | -2.03 | 5 | -7.97 | 3.57 | -0.65 | |
| Operating Cash Flow | -9.89 | 5.47 | -38.86 | -18.09 | -28.76 | |
| Capital Expenditures | -0.39 | -0.57 | -0.63 | -0.06 | -0.01 | |
| Investing Cash Flow | -0.39 | -0.57 | -0.63 | -0.06 | -0.01 | |
| Long-Term Debt Issued | 0.49 | 0.56 | 0.6 | - | - | |
| Total Debt Issued | 0.49 | 0.56 | 0.6 | - | - | |
| Long-Term Debt Repaid | -1.82 | -0.58 | -0.33 | - | - | |
| Net Debt Issued (Repaid) | -1.33 | -0.02 | 0.27 | - | - | |
| Issuance of Common Stock | 20.93 | 0.45 | 10.65 | 1.34 | 75.85 | |
| Other Financing Activities | -0.32 | -0.08 | 4.72 | - | - | |
| Financing Cash Flow | 19.28 | 0.35 | 15.64 | 1.34 | 75.85 | |
| Foreign Exchange Rate Adjustments | 0.01 | -0.07 | -0.01 | -0.2 | -0.06 | |
| Net Cash Flow | 9.01 | 5.19 | -23.86 | -17 | 47 | |
| Free Cash Flow | -10.27 | 4.9 | -39.49 | -18.15 | -28.78 | |
| Free Cash Flow Margin | -997.01% | 50086.97% | -1406.26% | -181.52% | - | |
| Free Cash Flow Per Share | -0.92 | 0.58 | -5.43 | -2.58 | -5.65 | |
| Levered Free Cash Flow | -4.8 | -7.61 | -27.18 | -6.8 | -15.28 | |
| Unlevered Free Cash Flow | -4.8 | -7.61 | -27.18 | -6.8 | -15.28 | |
| Change in Working Capital | -0.21 | 5.89 | -10.43 | 10.7 | 8.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.